You just read:

Lenus Therapeutics Announces the Result of Complete Wound Healing on the Index Lesion of the First Subject in an Ongoing Single-Masked Phase 2 Trial with RGN-137 Dermal Gel for Epidermolysis Bullosa

News provided by

Lenus Therapeutics, LLC

Aug 05, 2019, 14:00 ET